Yoga intervention for patients with systemic Lupus erythematous
- Conditions
- Health Condition 1: E888- Other specified metabolic disorders
- Registration Number
- CTRI/2021/05/033419
- Lead Sponsor
- Dr Shobana
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
New cases- All SLE patients fulfill the revised ACR classification criteria
malar and discoid rash, photosensitivity, oral ulcers, arthritis, serositis, renal, neurological, hematologic and immunologic disorder, and positive antinuclear antibody.
The presence of 4 out of 11 criteria is confirmed to be the diagnosis of SLE.
Resistant case- SLE patients unresponsive to previous treatment with one/ more successive/ simultaneous conventional immunosuppressive drugs for more than 6 months or had continuing requirement for a daily dose of �20 mg of steroids or its equivalent
Patients with severe form of SLE
ï?¶ââ??ª Patients with any other Inflammatory disorder & immune deficiency disorder.
ï?¶ââ??ª Patients with confirmed HIV infection
ï?¶ââ??ª Patients with acute infectious diseases & metastatic diseases
ï?¶ââ??ª Patients with Associated co-morbidity or depression or psychological illnesses
ï?¶ââ??ª Practicing yoga in the past 3 months
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Routine markers- Hb, WBC, DC, ESR, Urine R/E (preferably a fresh sample examined), Serum chemistry (urea, creatinine, liver function tests, lipid profile), Autoantibodies and complement- ANA, anti-dsDNA, anti-cardiolipin, C3, C4, Inflammatory markers: IL-6, IL-10, IL-17, TNF-alpha, Interferon-gamma <br/ ><br>Micro RNATimepoint: All the above parameters are measured at baseline and again at the end of intervention period i.e after 6 months.
- Secondary Outcome Measures
Name Time Method ILTimepoint: NI